TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 53 filers reported holding TRANSLATE BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $493,500,000 | +66.8% | 18,044,239 | 0.0% | 4.00% | +69.9% |
| Q1 2021 | $295,810,000 | -9.3% | 18,044,239 | 0.0% | 2.36% | -21.8% |
| Q4 2020 | $326,236,000 | +34.6% | 18,044,239 | 0.0% | 3.01% | +14.9% |
| Q3 2020 | $242,393,000 | -24.0% | 18,044,239 | 0.0% | 2.62% | -34.2% |
| Q2 2020 | $319,122,000 | +86.5% | 18,044,239 | +2.8% | 3.98% | +57.8% |
| Q1 2020 | $171,071,000 | +21.0% | 17,544,239 | 0.0% | 2.52% | +61.8% |
| Q4 2019 | $141,358,000 | -17.9% | 17,544,239 | 0.0% | 1.56% | -19.9% |
| Q3 2019 | $172,230,000 | +57.5% | 17,544,239 | +98.4% | 1.95% | +97.0% |
| Q2 2019 | $109,372,000 | +71.1% | 8,844,239 | +36.2% | 0.99% | +84.4% |
| Q1 2019 | $63,939,000 | +35.6% | 6,491,298 | +0.0% | 0.54% | +31.3% |
| Q4 2018 | $47,136,000 | -24.5% | 6,491,287 | 0.0% | 0.41% | -14.4% |
| Q3 2018 | $62,393,000 | +156.5% | 6,491,287 | +237.5% | 0.48% | +124.4% |
| Q2 2018 | $24,327,000 | – | 1,923,076 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 1,872,115 | $30,871,000 | 5.70% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $35,994,000 | 2.89% |
| Baupost Group | 18,044,239 | $295,810,000 | 2.36% |
| RTW INVESTMENTS, LP | 4,382,199 | $72,262,000 | 1.13% |
| DAFNA Capital Management LLC | 225,393 | $3,717,000 | 0.88% |
| Camber Capital Management LP | 1,150,000 | $18,964,000 | 0.65% |
| EcoR1 Capital, LLC | 596,900 | $9,843,000 | 0.44% |
| Alpha Paradigm Partners, LLC | 50,393 | $831,000,000 | 0.32% |
| Birchview Capital, LP | 30,000 | $495,000 | 0.29% |
| Artal Group S.A. | 1,000,000 | $16,490,000 | 0.29% |